An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes-Reference-Cited by-同舟云学术

An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes

Published:2015-06-15 Issue:8 Volume:47 Page:878-887
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Mohankumar Kumarasamypet M,Currle David S,White Elsie,Boulos Nidal,Dapper Jason,Eden Christopher,Nimmervoll Birgit,Thiruvenkatam Radhika,Connelly Michele,Kranenburg Tanya A^ORCID,Neale Geoffrey,Olsen Scott,Wang Yong-Dong,Finkelstein David,Wright Karen,Gupta Kirti,Ellison David W,Thomas Arzu Onar,Gilbertson Richard J

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.3323.pdf

Reference38 articles.

1. Schwab, M. et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305, 245–248 (1983).

2. Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753–756 (1994).

3. Zender, L. et al. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135, 852–864 (2008).

4. Johnson, R.A. et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466, 632–636 (2010).

5. Parker, M. et al. C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma. Nature 506, 451–455 (2014).

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural language processing charts transcriptome evolution to design combination cancer therapies;2024-04-09

2. Comparative interactome analysis of α-arrestin families in human and Drosophila;eLife;2024-01-25

3. Comparative interactome analysis of α-arrestin families in human and Drosophila;eLife;2024-01-25

4. Natural Language Processing Charts Transcriptome Evolution to Design Combination Cancer Therapies;2024

5. Biological, Diagnostic, and Therapeutic Insights from (Epi)Genomic Profiling of Pediatric Brain Tumors;Annual Review of Cancer Biology;2023-12-18